Back to search

Article

Role of Advanced Glycation End Products as New Biomarkers in Systemic Lupus Erythematosus

2024-02-02

Abstract excerpt

<h4>Introduction: </h4> Advanced glycation end-products (AGEs) may play a relevant role as inducers in the chronic inflammatory pathway present in immune-mediated diseases, such as systemic lupus erythematosus (SLE). AGEs concentrations have been associated, with discrepant results to date, with some parameters such as disease activity or accrual damage, suggesting their potential usefulness as biomarkers of the d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d8841157-bd99-5b15-9758-2411b9b719d9
DOI
10.20944/preprints202402.0079.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Role of Advanced Glycation End Products as New Biomarkers in Systemic Lupus ErythematosusDOI 10.20944/preprints202402.0079.v1
Select a neighboring publication to make it the new centre.